Organogermanium: Potential beneficial effects on the cardiovascular system

Area of Science:

• Biochemistry
• Cardiovascular Science
• Immunology

Background:

• Organogermanium compounds, particularly poly-trans-[(2-carboxyethyl)germasesquioxane] (Ge-132), are recognized for immune-modulatory activities.
• Emerging evidence suggests Ge-132 possesses unique, underappreciated multi-functional properties with potential cardiovascular benefits.

Purpose of the Study:

• To review the diverse in vivo and in vitro evidence highlighting Ge-132's potential positive effects on the cardiovascular system.
• To elucidate the molecular mechanisms underlying Ge-132's pleiotropic physiological effects relevant to cardiovascular health.

Main Methods:

• Analysis of existing literature on Ge-132's interactions with biological molecules (vicinal diols).
• Examination of Ge-132's impact on macrophage phagocytosis and the heme catabolic pathway.
• Review of studies detailing Ge-132's physiological effects, including anti-oxidation, anti-inflammation, and erythrocyte lifecycle enhancement.

Main Results:

• Ge-132 forms complexes with vicinal diols found in essential biomolecules like ATP, catecholamines, and glucose.
• Ge-132 upregulates enzymes in the heme catabolic pathway, increasing cytoprotective molecules (biliverdin, bilirubin).
• Oral Ge-132 intake results in pleiotropic effects: anti-oxidation, anti-inflammation, anti-hypertension, anti-glycation, and improved erythrocyte lifecycle.

Conclusions:

• Ge-132 exhibits multi-functional properties that positively impact the cardiovascular system through various physiological effects.
• Enhancement of the erythrocyte lifecycle by Ge-132 is crucial for vascular function, oxygen delivery, and erythropoiesis.
• Further human studies are necessary to confirm the translation of these beneficial effects in clinical settings.